301 related articles for article (PubMed ID: 24150846)
1. Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy.
Chua JP; Reddy SL; Merry DE; Adachi H; Katsuno M; Sobue G; Robins DM; Lieberman AP
Hum Mol Genet; 2014 Mar; 23(5):1376-86. PubMed ID: 24150846
[TBL] [Abstract][Full Text] [Related]
2. Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet.
Rocchi A; Milioto C; Parodi S; Armirotti A; Borgia D; Pellegrini M; Urciuolo A; Molon S; Morbidoni V; Marabita M; Romanello V; Gatto P; Blaauw B; Bonaldo P; Sambataro F; Robins DM; Lieberman AP; Sorarù G; Vergani L; Sandri M; Pennuto M
Acta Neuropathol; 2016 Jul; 132(1):127-44. PubMed ID: 26971100
[TBL] [Abstract][Full Text] [Related]
3. Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA.
Cortes CJ; Miranda HC; Frankowski H; Batlevi Y; Young JE; Le A; Ivanov N; Sopher BL; Carromeu C; Muotri AR; Garden GA; La Spada AR
Nat Neurosci; 2014 Sep; 17(9):1180-9. PubMed ID: 25108912
[TBL] [Abstract][Full Text] [Related]
4. p62/SQSTM1 differentially removes the toxic mutant androgen receptor via autophagy and inclusion formation in a spinal and bulbar muscular atrophy mouse model.
Doi H; Adachi H; Katsuno M; Minamiyama M; Matsumoto S; Kondo N; Miyazaki Y; Iida M; Tohnai G; Qiang Q; Tanaka F; Yanagawa T; Warabi E; Ishii T; Sobue G
J Neurosci; 2013 May; 33(18):7710-27. PubMed ID: 23637164
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Autophagic Response in The Muscle of A Knock-in Mouse Model of Spinal and Bulbar Muscular Atrophy.
Rusmini P; Polanco MJ; Cristofani R; Cicardi ME; Meroni M; Galbiati M; Piccolella M; Messi E; Giorgetti E; Lieberman AP; Milioto C; Rocchi A; Aggarwal T; Pennuto M; Crippa V; Poletti A
Sci Rep; 2015 Oct; 5():15174. PubMed ID: 26490709
[TBL] [Abstract][Full Text] [Related]
6. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.
Rusmini P; Cortese K; Crippa V; Cristofani R; Cicardi ME; Ferrari V; Vezzoli G; Tedesco B; Meroni M; Messi E; Piccolella M; Galbiati M; Garrè M; Morelli E; Vaccari T; Poletti A
Autophagy; 2019 Apr; 15(4):631-651. PubMed ID: 30335591
[TBL] [Abstract][Full Text] [Related]
7. Progress in Spinobulbar muscular atrophy research: insights into neuronal dysfunction caused by the polyglutamine-expanded androgen receptor.
Beitel LK; Scanlon T; Gottlieb B; Trifiro MA
Neurotox Res; 2005; 7(3):219-30. PubMed ID: 15897156
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Tanaka F; Adachi H; Banno H; Suzuki K; Watanabe H; Sobue G
Prog Neurobiol; 2012 Dec; 99(3):246-56. PubMed ID: 22609045
[TBL] [Abstract][Full Text] [Related]
9. Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease.
Chua JP; Reddy SL; Yu Z; Giorgetti E; Montie HL; Mukherjee S; Higgins J; McEachin RC; Robins DM; Merry DE; Iñiguez-Lluhí JA; Lieberman AP
J Clin Invest; 2015 Feb; 125(2):831-45. PubMed ID: 25607844
[TBL] [Abstract][Full Text] [Related]
10. Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in Mice.
Galbiati M; Meroni M; Boido M; Cescon M; Rusmini P; Crippa V; Cristofani R; Piccolella M; Ferrari V; Tedesco B; Casarotto E; Chierichetti M; Cozzi M; Mina F; Cicardi ME; Pedretti S; Mitro N; Caretto A; Risè P; Sala A; Lieberman AP; Bonaldo P; Pennuto M; Vercelli A; Poletti A
Neurotherapeutics; 2023 Mar; 20(2):524-545. PubMed ID: 36717478
[TBL] [Abstract][Full Text] [Related]
11. Rescue of Metabolic Alterations in AR113Q Skeletal Muscle by Peripheral Androgen Receptor Gene Silencing.
Giorgetti E; Yu Z; Chua JP; Shimamura R; Zhao L; Zhu F; Venneti S; Pennuto M; Guan Y; Hung G; Lieberman AP
Cell Rep; 2016 Sep; 17(1):125-136. PubMed ID: 27681426
[TBL] [Abstract][Full Text] [Related]
12. Distinct Etiological Roles for Myocytes and Motor Neurons in a Mouse Model of Kennedy's Disease/Spinobulbar Muscular Atrophy.
Ramzan F; McPhail M; Rao P; Mo K; Halievski K; Swift-Gallant A; Mendoza-Viveros L; Cheng HY; Monks DA
J Neurosci; 2015 Apr; 35(16):6444-51. PubMed ID: 25904795
[TBL] [Abstract][Full Text] [Related]
13. Enhanced aggregation of androgen receptor in induced pluripotent stem cell-derived neurons from spinal and bulbar muscular atrophy.
Nihei Y; Ito D; Okada Y; Akamatsu W; Yagi T; Yoshizaki T; Okano H; Suzuki N
J Biol Chem; 2013 Mar; 288(12):8043-8052. PubMed ID: 23364790
[TBL] [Abstract][Full Text] [Related]
14. [Triplet repeat disease, with particular emphasis of spinal and bulbar muscular atrophy (SBMA)].
Sobue G
Rinsho Shinkeigaku; 2000 Dec; 40(12):1193-5. PubMed ID: 11464455
[TBL] [Abstract][Full Text] [Related]
15. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy.
Cortes CJ; Ling SC; Guo LT; Hung G; Tsunemi T; Ly L; Tokunaga S; Lopez E; Sopher BL; Bennett CF; Shelton GD; Cleveland DW; La Spada AR
Neuron; 2014 Apr; 82(2):295-307. PubMed ID: 24742458
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors.
Iida M; Katsuno M; Nakatsuji H; Adachi H; Kondo N; Miyazaki Y; Tohnai G; Ikenaka K; Watanabe H; Yamamoto M; Kishida K; Sobue G
Hum Mol Genet; 2015 Jan; 24(2):314-29. PubMed ID: 25168383
[TBL] [Abstract][Full Text] [Related]
17. Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes.
Milioto C; Malena A; Maino E; Polanco MJ; Marchioretti C; Borgia D; Pereira MG; Blaauw B; Lieberman AP; Venturini R; Plebani M; Sambataro F; Vergani L; Pegoraro E; Sorarù G; Pennuto M
Sci Rep; 2017 Jan; 7():41046. PubMed ID: 28117338
[TBL] [Abstract][Full Text] [Related]
18. Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy.
Lieberman AP; Yu Z; Murray S; Peralta R; Low A; Guo S; Yu XX; Cortes CJ; Bennett CF; Monia BP; La Spada AR; Hung G
Cell Rep; 2014 May; 7(3):774-84. PubMed ID: 24746732
[TBL] [Abstract][Full Text] [Related]
19. [Molecular-targeted therapy for spinal and bulbar muscular atrophy (SBMA)].
Sobue G
Rinsho Shinkeigaku; 2010 Nov; 50(11):839-41. PubMed ID: 21921465
[TBL] [Abstract][Full Text] [Related]
20. LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice.
Prakasam R; Bonadiman A; Andreotti R; Zuccaro E; Dalfovo D; Marchioretti C; Tripathy D; Petris G; Anderson EN; Migazzi A; Tosatto L; Cereseto A; Battaglioli E; Sorarù G; Lim WF; Rinaldi C; Sambataro F; Pourshafie N; Grunseich C; Romanel A; Pandey UB; Contestabile A; Ronzitti G; Basso M; Pennuto M
Nat Commun; 2023 Feb; 14(1):603. PubMed ID: 36746939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
